A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection

NCT00000663 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: CD4-IgG

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]